Stay updated on Nivolumab After Salvage Resection in Head and Neck Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab After Salvage Resection in Head and Neck Cancer Clinical Trial page.

Latest updates to the Nivolumab After Salvage Resection in Head and Neck Cancer Clinical Trial page
- Check5 days agoChange DetectedThe page now displays Revision: v3.3.4 in place of Revision: v3.3.3.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check27 days agoChange DetectedThe Locations section now lists Michigan and Ohio as study sites and the page revision updated to v3.3.3. The HHS Vulnerability Disclosure link and the previous Michigan/Ohio Locations entries were removed.SummaryDifference0.4%

- Check55 days agoChange DetectedPublication notes now state that PubMed auto-fill may not all be about the study. The revision version has been updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check62 days agoChange DetectedRemoved the government funding lapse notice and its operating-status reference from the page; no study data, eligibility criteria, or trial details were changed.SummaryDifference0.4%

- Check77 days agoChange DetectedThe two screenshots show only minor UI/layout adjustments; core study data (eligibility criteria, primary outcomes, and enrollment) appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check105 days agoChange Detected- Removed version v3.1.0 and added notice about government funding lapse and current NIH Clinical Center status with links, plus new version tag v3.2.0. Overall, the page now communicates current operating status and a newer version rather than the old one.SummaryDifference6%

Stay in the know with updates to Nivolumab After Salvage Resection in Head and Neck Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab After Salvage Resection in Head and Neck Cancer Clinical Trial page.